Are you deeply engaged in hepatology and science and ready to get involved in EASL’s governance? EASL is now looking to fill the following position: One Educational Committee member Two AI Task Force members To apply, please connect to the Member Zone. Deadline:…
EASL is proud to announce that both of its journals have achieved outstanding new Impact Factors in the 2026 release of the Journal Citation Reports (JCR) by Clarivate™, reflecting their continued scientific excellence and growing influence within the global hepatology…
London, 24 June 2026 — The WHO Regional Office for Europe, Imperial College London and EASL inaugurate the first WHO Collaborating Centre dedicated to liver disease, at a ceremony at Imperial's White City Campus attended by WHO Regional Director for…
EASL and Content With Purpose (CWP) have announced a new partnership to create The Future of Liver Health, an ambitious digital film series exploring how science, prevention, and innovation are transforming hepatology and shaping healthier futures across Europe and beyond…
PRESS RELEASE Geneva, 22 May 2026 For the first time, liver disease receives formal recognition within the global noncommunicable disease agenda — EASL hails the adoption of WHO resolution EB158/CONF./7 as a turning point for liver health worldwide Geneva, Switzerland…
EASL is deeply saddened by the passing of Dr Hannes Hagström, Consultant Hepatologist at Karolinska University Hospital and Professor at Karolinska Institutet. Hannes was not only an exceptional clinician scientist, but also a deeply valued colleague, collaborator, mentor, and friend…
The EASL General Assembly will take place on Friday, 29 May 2026, from 18:45 to 20:00 during EASL Congress 2026 in Barcelona. The meeting will be held in person in the Mondelli Room. Please note that an active EASL Membership…
The EASL community is deeply saddened by the loss of Dr Ahmed Elsharkawy, consultant transplant hepatologist, researcher, educator, and valued member of the EASL Governing Board. Ahmed served on the EASL Governing Board as EASL Internal Affairs Councillor from November…
THRIVE ACTIVITIES AT EASL LIVER CANCER SUMMIT 2026 The overall aim of the THRIVE project is to improve the outcome of both paediatric and adult liver cancer patients by understanding at-risk populations, tumour-host molecular interactions, developing biomarkers for current…
Are you deeply engaged in hepatology and science and ready to get involved in EASL’s governance? EASL is now looking to fill the following position: One Nurses & Allied Health Professionals (AHPs) Task Force Member To apply, please connect to the Member Zone.